As we have previously shown, the IL-2/IL-15/IL-21 cocktail is able to preferentially trigger expansion of antigen-specific, highly activated CD8+ TIL, that are not immunologically exhausted and are capable of killing autologous GBM cells in vitro. The gene discussed is IL21; the disease is glioblastoma.